|1.||Meltzer, Herbert Y: 4 articles (04/2010 - 01/2003)|
|2.||Bobo, William V: 2 articles (04/2010 - 07/2009)|
|3.||Jayathilake, Karuna: 2 articles (04/2010 - 07/2009)|
|4.||Lee, Myung A: 2 articles (04/2010 - 07/2009)|
|5.||Sumiyoshi, Tomiki: 2 articles (07/2003 - 01/2003)|
|6.||Jayathilake, Karu: 2 articles (07/2003 - 01/2003)|
|7.||Hiemke, Christoph: 1 article (06/2014)|
|8.||Geschke, Katharina: 1 article (06/2014)|
|9.||Hefner, Gudrun: 1 article (06/2014)|
|10.||Lai, Jin-Wang: 1 article (12/2012)|
|1.||Schizophrenia (Dementia Praecox)
02/01/2011 - "This case series examines the efficacy of melperone in refractory schizophrenia. "
12/31/2001 - "The results suggest that a proportion of neuroleptic-resistant patients with schizophrenia respond to melperone, which requires further controlled study."
12/31/2001 - "In this study, melperone was administered, in an open trial design of 6 weeks' duration, to 44 patients with chronic neuroleptic-resistant schizophrenia. "
01/01/2012 - "Auditing clinical outcomes after introducing off-licence prescribing of atypical antipsychotic melperone for patients with treatment refractory schizophrenia."
02/01/2011 - "Melperone in treatment-refractory schizophrenia: a case series."
|2.||Psychomotor Agitation (Akathisia)
11/01/2004 - "Prior to her hospitalization, she had been treated with Melperone for restlessness. "
01/01/1991 - "Melperon eliminates anxiety and restlessness]."
01/01/1998 - "In that study, tiapride as a drop formulation compared with melperone was safe and effective with regard to restlessness and aggressive behaviour in elderly patients."
01/01/1988 - "A double-blind study was carried out in 53 elderly patients in 6 geriatric nursing homes to assess the effectiveness of the neuroleptics, zuclopenthixol and melperon (flubuperone), in the relief of restlessness, aggressiveness and other such symptoms. "
|3.||Alzheimer Disease (Alzheimer's Disease)
12/01/2012 - "Melperone is an atypical antipsychotic agent that has shown a wide spectrum of neuroleptic properties, particularly effective in the treatment of senile dementia and Parkinson's-associated psychosis, and is marketed in Europe as an immediate-release (IR) tablet and syrup. "
01/01/1967 - "[Buronil and promazine therapy of patients with senile dementia. "
04/01/1983 - "Seventeen older patients with a diagnosis of Organic Brain Syndrome were placed on a four-week trial of melperone for treatment of behavioural disturbances associated with dementia. "
04/01/1983 - "An open dose finding study of melperone in treatment of agitation and irritability associated with dementia."
01/01/1997 - "Therefore, a multi-centre, double-blind, randomized study, measuring the efficacy and safety of tiapride vs. melperone in hospitalized dementia patients suffering from psychomotoric agitation, was conducted in 24 psychiatric hospitals in Germany. "
01/01/1981 - "17 female and 20 male patients, aged 33-97 years, most of them with the diagnoses: schizophrenia (11 patients), dementia organica (11 patients) and dementia senilis (11 patients) were treated with melperone (Buronil) in doses of 15--800 mg/day for 1 to 15 years. "
07/01/2012 - "The rate of antipsychotic drug prescribing was significantly doubled in NHR with dementia compared to those without this diagnosis (p<0.01); the most frequently prescribed antipsychotics were melperone, risperidone and pipamperone. "
|5.||Levodopa (L Dopa)